Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss HALO - Halozyme Therapeutics, Inc.
3.83 M
LAST VALUE
148.05%
2 YEAR CAGR
74.01%
5 YEAR CAGR
57.74%
10 YEAR CAGR